Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rivaroxaban Tablets

Approval Number

国药准字H20227005

Company南京正大天晴制药有限公司

Registration Date

January 18, 2022

Previous Approval Numbers

国药准字H20203354

Drug Information

Generic Name

利伐沙班片

Dosage Form

片剂

Strength

15mg

Drug Type

化学药品

Registration Date

January 18, 2022

Company Information

Applicant Company

Company Name南京正大天晴制药有限公司

Company Address

南京经济技术开发区惠欧路9号

Manufacturing Company

Company Name南京正大天晴制药有限公司

Company Address

南京经济技术开发区惠欧路9号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

利伐沙班片 - NMPA 批准文号 | MedPath